Rep. Daniel S. Goldman sold Natera (NTRA)
Rep. Daniel S. Goldman (D-NY-10) · $1K–$15K · traded Apr 10, 2023
- Transaction
- Sold (partial)
- Amount
- $1K–$15K
- Owner
- Not stated
- Traded
- Apr 10, 2023
- Disclosed
- May 19, 2023
- Days to disclose
- 39
- Asset type
- Stock
- As filed
- Natera, Inc.
- Industry
- Medical - Diagnostics & Research · Healthcare
Other trades in this filing
All of Goldman's trades →- May 19, 2023$250K–$500K
Bought N Y ST ENV FACS CORP REV 5% 05/15/26 MN
$250K–$500K · Traded Apr 26, 2023 · disclosed May 19, 2023
- May 19, 2023$250K–$500K
Sold SOUTH ORANGE VLG TWP N J GO 4% 01/15/27
$250K–$500K · Traded Apr 25, 2023 · disclosed May 19, 2023
- May 19, 2023$250K–$500K
Sold HOOVER ALA GO 4% 07/01/36 JJ
$250K–$500K · Traded Apr 25, 2023 · disclosed May 19, 2023
- May 19, 2023$250K–$500K
Sold EWING TWP N J GO 4% 11/15/25 MN
$250K–$500K · Traded Apr 25, 2023 · disclosed May 19, 2023
- May 19, 2023$100K–$250K
Bought SCHENECTADY N Y GO 4% 05/01/26 MN
$100K–$250K · Traded Apr 20, 2023 · disclosed May 19, 2023
- May 19, 2023$100K–$250K
Sold NEW JERSEY (STATE OF) GO 5% 06/01/28 JD
$100K–$250K · Traded Apr 19, 2023 · disclosed May 19, 2023
- May 19, 2023$250K–$500K
Bought N Y CITY MUN WTR FIN AUTH REV 5.0000% 06/15/31 JD
$250K–$500K · Traded Apr 19, 2023 · disclosed May 19, 2023
- May 19, 2023$250K–$500K
Bought COLONIE N Y GO 4% 03/08/24 MS
$250K–$500K · Traded Apr 19, 2023 · disclosed May 19, 2023
- May 19, 2023$500K–$1M
Sold N J ENV INFRASTRUCTURE TR REV 4% 09/01/27-CA MS
$500K–$1M · Traded Apr 19, 2023 · disclosed May 19, 2023
- May 19, 2023$1K–$15K
Bought TELSTRA GROUP LTD SPONSORED ADR CMN (TLGPY)
$1K–$15K · Traded Apr 13, 2023 · disclosed May 19, 2023
- May 19, 2023$1K–$15K
Bought SOFTBANK CORP. ADR CMN (SOBKY)
$1K–$15K · Traded Apr 13, 2023 · disclosed May 19, 2023
- May 19, 2023$250K–$500K
Bought DORM AUTH OF THE STATE OF NY REV 5.0000% 10/01/26 AO
$250K–$500K · Traded Apr 13, 2023 · disclosed May 19, 2023
- May 19, 2023$15K–$50K
$15K–$50K · Traded Apr 13, 2023 · disclosed May 19, 2023
- May 19, 2023$50K–$100K
$50K–$100K · Traded Apr 13, 2023 · disclosed May 19, 2023
- May 19, 2023$1K–$15K
Bought Computershare Limited CMSQY
$1K–$15K · Traded Apr 13, 2023 · disclosed May 19, 2023
- May 19, 2023$1K–$15K
Bought Qantas Airways Limited QABSY
$1K–$15K · Traded Apr 13, 2023 · disclosed May 19, 2023
- May 19, 2023$1K–$15K
Sold (partial) MIAMI-DADE CNTY FLA 5% 07-01- 2025 BEO
$1K–$15K · Traded Apr 13, 2023 · disclosed May 19, 2023
- May 19, 2023$1K–$15K
Bought West Japan Railway Company WJRYY
$1K–$15K · Traded Apr 13, 2023 · disclosed May 19, 2023
- May 19, 2023$1K–$15K
Bought Central Japan Railway Company CJPRY
$1K–$15K · Traded Apr 13, 2023 · disclosed May 19, 2023
- May 19, 2023$100K–$250K
Bought LOCKPORT CITY N Y SCH DIST GO 5% 04/15/28 AO
$100K–$250K · Traded Apr 12, 2023 · disclosed May 19, 2023
Recent Congress trades in NTRA
- Oct 15, 2025$1K–$15K
Rep. Josh Gottheimer (D-NJ-5)
$1K–$15K · Traded Sep 22, 2025 · disclosed Oct 15, 2025 · Joint
- Sep 5, 2025$1K–$15K
Rep. Josh Gottheimer (D-NJ-5)
$1K–$15K · Traded Aug 22, 2025 · disclosed Sep 5, 2025 · Joint
- Aug 11, 2025$1K–$15K
Rep. Josh Gottheimer (D-NJ-5)
$1K–$15K · Traded Jul 22, 2025 · disclosed Aug 11, 2025 · Joint
- Dec 5, 2024$1K–$15K
Rep. Josh Gottheimer (D-NJ-5)
$1K–$15K · Traded Nov 20, 2024 · disclosed Dec 5, 2024 · Joint
- Apr 17, 2023$1K–$15K
Rep. Daniel S. Goldman (D-NY-10)
$1K–$15K · Traded Mar 6, 2023 · disclosed Apr 17, 2023
- May 4, 2021$1K–$15K
Sen. Bill Hagerty (R-TN)
$1K–$15K · Traded Apr 20, 2021 · disclosed May 4, 2021
Company context for NTRA
Recent records for the company. These may have been published before or after this trade; compare the dates before drawing a connection.
NTRA: third_quarter 2026 lobbying report
Insurance coverage for laboratory testing.
Public: Oct 19, 2026, 3:02 PM EDTOriginal source ↗NTRA: third_quarter 2026 lobbying report
Health issues. Medicare/Medicaid issues. H.R.5269: RESULTS Act.
Public: Oct 19, 2026, 7:34 AM EDTOriginal source ↗NTRA: third_quarter 2026 lobbying report
Advocacy on importance of FDA's oversight of Laboratory Developed Tests and impact on industry and patients. Advocacy on CMS administrative procedures regarding Date of Service (DOS) for Laboratory testing for patients.
Public: Oct 16, 2026, 4:00 PM EDTOriginal source ↗
From a periodic transaction report filed under the STOCK Act. Amounts are the ranges members report. Nothing here is investment advice.